{"id":892,"date":"2021-04-07T04:49:09","date_gmt":"2021-04-07T04:49:09","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=892"},"modified":"2021-04-07T04:49:09","modified_gmt":"2021-04-07T04:49:09","slug":"04-mar-2021-nitazoxanide-significant-viral-load-reduction-%e2%89%a5-35-from-baseline-up-to-day-7-of-treatment","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/04-mar-2021-nitazoxanide-significant-viral-load-reduction-%e2%89%a5-35-from-baseline-up-to-day-7-of-treatment\/","title":{"rendered":"(04 Mar 2021) Nitazoxanide- significant viral load reduction \u2265 35% from baseline up to day 7 of treatment"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p id=\"page-title\" class=\"highwire-cite-title\">Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study<\/p>\n<p class=\"\">https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.03.21252509v1<\/p>\n<p class=\"\">NCT04463264- The objective of this study was to evaluate the efficacy and safety of Nitazoxanide in reducing the SARS-COV 2 viral load within 7 days of treatment in respiratory samples from COVID-19-infected patients with mild to moderate disease, compared to placebo. An interim analysis showed that the ratio of patients with a viral load reduction \u2265 35% from baseline up to day 7 of treatment was significantly greater for Nitazoxanide compared to placebo (47.8% vs. 15.4%; \u0394 34.6%; 95% CI: 64.7; 4.6:&nbsp;<em>p<\/em>&nbsp;= 0.037).<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study https:\/\/www.medrxiv.org\/content\/10.1101\/2021.03.03.21252509v1 NCT04463264- The objective of this study was to evaluate the efficacy and safety of Nitazoxanide in reducing the SARS-COV 2 viral&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/04-mar-2021-nitazoxanide-significant-viral-load-reduction-%e2%89%a5-35-from-baseline-up-to-day-7-of-treatment\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(04 Mar 2021) Nitazoxanide- significant viral load reduction \u2265 35% from baseline up to day 7 of treatment&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[6,4,85],"tags":[86],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/892"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=892"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/892\/revisions"}],"predecessor-version":[{"id":893,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/892\/revisions\/893"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}